´ºÓêÖ±²¥app

´ºÓêÖ±²¥app

Completion of the Clinical Study: A Safety Trial of Allogeneic iPS Cell¨CDerived Regenerated Cardiomyocyte Spheroid Transplantation in Patients with Refractory Severe Heart Failure

Publish: February 20, 2024
School of Medicine/Graduate School of Medicine

For more details, please visit the link below.